Treating Cancer by Disrupting Energy and Building Block Needs
With time, effort, and commitment to collaborative research, Madera of Cary, North Carolina, focuses on identifying and developing small molecule therapeutics to treat cancers. Our strategy is designed to disrupt the metabolic pathways of tumorigenic cells through the selective modulation of mitochondrial proteases. Contact our company for additional details about our research.
Our mission is to identify and develop cancer therapeutics that treat cancer by disrupting a tumor and its environment’s unique energy requirements.